D-0597-2026 Class II Ongoing
FDA drug recall D-0597-2026 was initiated by Ascend Laboratories, LLC on Jun 1, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis The recall status is ongoing. Affected quantity: 360 30-count bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jun 17, 2026
- Initiation Date
- Jun 1, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 360 30-count bottles
Product description
Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30
Reason for recall
Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis
Distribution pattern
Nationwide in the USA
Code information
Lot# 25141635, Exp 4/30/2028
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0597-2026
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for Ascend Laboratories, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.